Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο:
https://hdl.handle.net/20.500.14279/3666
Τίτλος: | Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis | Συγγραφείς: | McCormick, Jonathan D. Mehta, Gita R. Olesen, Hanne Vebert Ebert Viviani, Laura Macek, Milan St Mehta, Anil Yiallouros, Panayiotis K. |
Major Field of Science: | Medical and Health Sciences | Field Category: | Clinical Medicine | Λέξεις-κλειδιά: | Lung;Pulmonary exacerbation;Cystic fibrosis | Ημερομηνία Έκδοσης: | 2010 | Πηγή: | The Lancet, 2010, vol. 375, no. 9719, pp. 1007–1013 | Volume: | 375 | Issue: | 9719 | Start page: | 1007 | End page: | 1013 | Περιοδικό: | The Lancet | Περίληψη: | Background: Country-specific patients' registries are rarely used to make international comparisons because of protocol discrepancies in data collation. We present data from a European cystic fibrosis registry that is dedicated to collection of demographic data, and assess whether the resources available in countries with and without European Union (EU) membership affects care and survival of patients. Methods: Data for demographic indicators-age, age at diagnosis, sex, and genotype-for patients with cystic fibrosis from 35 European countries were combined, and used to establish the differences in demographic indicators between EU and non-EU countries. EU membership status in 2003 was used to divide countries. We modelled demographic indicators of EU countries on non-EU countries to estimate the size of the cystic fibrosis population if non-EU countries had had the same resources available for patients as did EU countries. Findings: Data were gathered for 29 025 patients, who had a median age of 16·3 years (IQR 8·9-24·8), with a difference of 4·9 years (95% CI 4·4-5·1; p<0·0001) between EU (median 17·0 years, IQR 9·5-25·6) and non-EU countries (12·1 years, 6·0-19·2). The proportion of patients older than 40 years was higher in EU countries (1205 [5%]) than in non-EU countries (76 [2%]), with an odds ratio of 2·4 (95% CI 1·9-3·0, p<0·0001). We estimated that the cystic fibrosis population in non-EU countries would increase by 84% if patients had a demographic profile comparable to that of patients in EU countries. Interpretation: Future studies need to establish the reasons for the lower proportion of patients with cystic fibrosis in non-EU countries than in EU countries, such as underdiagnosis and premature childhood mortality. Funding: European Community's Sixth Framework Programme for Research, and Czech Ministry of Health. | URI: | https://hdl.handle.net/20.500.14279/3666 | ISSN: | 01406736 | DOI: | 10.1016/S0140-6736(09)62161-9 | Rights: | © Elsevier | Type: | Article | Affiliation: | University of Dundee Aarhus University Università degli Studi di Milano Charles University Cyprus University of Technology |
Publication Type: | Peer Reviewed |
Εμφανίζεται στις συλλογές: | Άρθρα/Articles |
CORE Recommender
SCOPUSTM
Citations
115
checked on 9 Νοε 2023
WEB OF SCIENCETM
Citations
103
Last Week
0
0
Last month
0
0
checked on 29 Οκτ 2023
Page view(s) 20
487
Last Week
1
1
Last month
8
8
checked on 28 Αυγ 2024
Google ScholarTM
Check
Altmetric
Όλα τα τεκμήρια του δικτυακού τόπου προστατεύονται από πνευματικά δικαιώματα